Stefan Bittner
Overview
Explore the profile of Stefan Bittner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
211
Citations
3420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gabele A, Sprang M, Cihan M, Welzel M, Nurbekova A, Romaniuk K, et al.
Cell Rep
. 2025 Mar;
44(3):115407.
PMID: 40067830
The transcription factor interferon regulatory factor 4 (IRF4) is crucial for the fate determination of pro-inflammatory T helper (Th) 17 and the functionally opposing group of immunomodulatory regulatory T (Treg)...
2.
Fleischer V, Brummer T, Muthuraman M, Steffen F, Heldt M, Protopapa M, et al.
Front Immunol
. 2025 Feb;
16:1532660.
PMID: 39958357
Objective: Establishing biomarkers to predict multiple sclerosis (MS) disability accrual has been challenging using a single biomarker approach, likely due to the complex interplay of neuroinflammation and neurodegeneration. Here, we...
3.
Mercadier J, Bittner S, Rontani D, Sciamanna M
Opt Lett
. 2025 Jan;
50(3):796-799.
PMID: 39888757
We experimentally report on the detection of chaos from a free-running commercial broad-area vertical-cavity surface-emitting laser (VCSEL) without the need for external perturbation such as optical feedback, injection, or current...
4.
Koerbel K, Yalachkov Y, Rotter T, Schaller-Paule M, Schaefer J, Friedauer L, et al.
Int J Mol Sci
. 2025 Jan;
26(2).
PMID: 39859463
Impaired renal function can influence biomarker levels through mechanisms involving blood-brain barrier integrity and clearance pathways; however, the impact of variations within normal renal function remains unclear. The main aim...
5.
Maiworm M, Koerbel K, Anschutz V, Jakob J, Schaller-Paule M, Schafer J, et al.
J Neurol
. 2025 Jan;
272(2):147.
PMID: 39812717
Background: BDNF has increasingly gained attention as a key molecule controlling remyelination with a prominent role in neuroplasticity and neuroprotection. Still, it remains unclear how BDNF relates to clinicoradiological characteristics...
6.
Protopapa M, Steffen F, Schraad M, Ruck T, Ozturk M, Hanuscheck N, et al.
Ann Neurol
. 2024 Nov;
97(3):596-605.
PMID: 39588882
Objective: We examined the impact of the rs10191329 genetic risk variant on neuroaxonal damage as measured by serum neurofilament light chain (sNfL) levels, and disability progression in people with multiple...
7.
Protopapa M, Schraad M, Pape K, Steffen F, Steenken L, Zipp F, et al.
Med
. 2024 Nov;
6(3):100529.
PMID: 39515320
Background: As B cell-depleting therapies in multiple sclerosis (MS) have gained significant importance in the last several years, their long-term safety profile is of considerable clinical interest. Late-onset neutropenia (LON)...
8.
Protopapa M, Schmaul S, Schraad M, Pape K, Zipp F, Bittner S, et al.
Ther Adv Neurol Disord
. 2024 Oct;
17:17562864241286497.
PMID: 39479177
Background: Interferon-beta (IFN-β) still plays a fundamental role in immunomodulation of people with multiple sclerosis (MS) with low disease activity and in clinically isolated syndrome (CIS). In 2014, pegylated (PEG)...
9.
Winter Y, Simon O, Spreer A, Othman A, Altmann S, Brandt M, et al.
Int J Stroke
. 2024 Sep;
20(2):205-214.
PMID: 39295077
Background: Neuroborreliosis is a tick-borne condition that affects the central and/or peripheral nervous system. Cerebral infarction associated with neuroborreliosis-related vasculitis has been reported in only a handful of cases. Therefore,...
10.
Gonzalez-Escamilla G, Fleischer V, Mongay-Ochoa N, Person M, Martschenko M, Ciolac D, et al.
Brain Stimul
. 2024 Aug;
17(5):980-982.
PMID: 39154801
No abstract available.